Gene One Life Science says VGXI’s USD 2 million first option-payment date under buyback extension is under renegotiation

Bitget2026/10/08 10:43

Gene One Life Science issued a correction on Oct. 8 to a subsidiary disclosure tied to VGXI’s buyback option for its Conroe plant. The filing removed the Oct. 7 payment date for the first USD 2 million deposit, citing ongoing talks to delay the payment. The total buyback exercise amount remains USD 39.9 million, with a revised contract expected to trigger another correction filing. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gene One Life Science Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261008800890), on October 08, 2026, and is solely responsible for the information contained therein.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Gene One Life Science issued a correction on Oct. 8 to a subsidiary disclosure tied to VGXI’s buyback option for its Conroe plant.
The filing removed the Oct. 7 payment date for the first USD 2 million deposit, citing ongoing talks to delay the payment.
The total buyback exercise amount remains USD 39.9 million, with a revised contract expected to trigger another correction filing.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gene One Life Science Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261008800890), on October 08, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Gene One Life Science says VGXI’s USD 2 million first option-payment date under buyback extension is under renegotiation

You may also like

Crypto prices